Original Research

Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts

Kimmel, Simeon D. MD, MA; Rosenmoss, Sophie BA; Bearnot, Benjamin MD, MPH; Larochelle, Marc MD, MPH; Walley, Alexander Y. MD, MSc

Author Information

Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA (SDK, SR, MLR, AYW); The Grayken Center for Addiction, Boston Medical Center (SDK, MLR, AYW); Division of General Internal Medicine and Mongan Institute, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (BB).

Send correspondence to Simeon D. Kimmel, MD, MA, Department of Medicine, Boston Medical Center, 801 Massachusetts Avenue, Crosstown Center, 2nd Floor, Boston, MA 02118. E-mail: [email protected].

Received 10 January, 2020

Accepted 23 March, 2020

Dr. Kimmel reports support from the National Institute on Drug Abuse (NIDA) (R25DA013582, R25DA033211), and the National Institute of Allergy and Infectious Diseases (5T32AI052074). He consults for Abt Associates on a Massachusetts Department of Public Health project to expand access to medications for opioid use disorder in post-acute care medical care facilities. Ms. Rosenmoss was supported by the Boston University School of Medicine's Medical Student Summer Research Program. Dr. Bearnot was supported by NIDA (K12DA043490). Dr. Larochelle was supported by NIDA (K23 DA042168) and a Boston University School of Medicine Department of Medicine Career Investment Award. Dr. Walley also reports support from NIDA (R25DA013582) and works as the medical director of the overdose prevention program at the Massachusetts Department of Public Health.

The authors have no conflicts of interests to disclose.

Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal's Web site (www.journaladdictionmedicine.com).

Journal of Addiction Medicine 15(1):p 20-26, January/February 2021. | DOI: 10.1097/ADM.0000000000000693

Buy
SDC
Erratum

Abstract

Erratum

In the article by Kimmel et al, appearing in the Journal of Addiction Medicine, Vol. 15, No. 1, pp. 20-26 entitled “Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts”, there is an error in reporting the insurance distributions in the Results section and within Table 1.

In the sentence “The cohort was largely white (54.3%), English speaking (92.2%), received OAT in the hospital or on discharge (87.7%), and was insured by Medicaid (53.4%),” the “53.4%” with Medicaid insurance should have been updated to read “56.6%”.

In Table 1, within the Insurance section, under the Value heading, “53% (117)” should have been updated to read “57% (124)”, “15% (32)” should have been updated to read “9.1% (20)”, and “0.9% (2)” should have been updated to read “3.2% (7)”.

Journal of Addiction Medicine. 17(1):121, January/February 2023.